Home » So, When Will Children and Teenagers Get the COVID-19 Vaccine? This is what the Minister of Health said

So, When Will Children and Teenagers Get the COVID-19 Vaccine? This is what the Minister of Health said

by archyw

President Joko Widodo said that COVID-19 vaccination for ages 12-17 can start immediately. The Indonesian Food and Drug Supervisory Agency (BPOM) has provided emergency use authorization (EUA) so that the Sinovac vaccine can be used at that age.

So when will children and teens be able to be vaccinated? Health Minister Budi Gunadi Sadikin said Sinovac is not the only vaccine that will be used in children and adolescents. There will be more to come in August.

“There are already. There are two vaccines that can be done under 18 (years old) who have received it emergency use authorizationit,” said the Minister of Health, met at the COVID-19 vaccination event in collaboration with CT Corp and the Ministry of Health at Trans Studio Mall Cibubur, Monday (28/6/2021).

“One, the Sinovac that we use, the other Pfizer, which will arrive around August. But that’s later, Mr. President, who will deliver,” he continued.

In the afternoon, President Jokowi in a virtual press release from the State Palace said BPOM had issued a permit for the Sinovac vaccine to be used in children aged 12-17 years.

“We are also grateful that BPOM has issued a permit emergency use authorization for the Sinovac vaccine which is declared safe for children aged 12-17 years,” said Jokowi, Monday (18/6/2021).

“So that vaccination for that age can be started immediately,” he continued.

BPOM has not yet issued an official statement regarding this matter. But recently, a letter circulated about the results of the evaluation of the Sinovac vaccine, the results of which recommended that use in children 12-17 years old was safe and effective.

Read Also:  1165 people in quarantine at Gjøvik - kindergartens and schools to the red level - VG

“From the safety data of phase I and phase II clinical trials, the profile of Systemic AE is: fever in the population of 12-17 years, it is not reported compared to the age of 3-5 years and 6-11 years,” explained BPOM, quoted from the circular of clinical trial evaluation results received by detikcom Sunday (27/6/2021).



0 comment

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.